Trial Profile
A Randomized, Open-label, 3-way Crossover Clinical Trial to Compare The Pharmacokinetics of A Pregabalin GLARS Tablet 150mg With Immediate Release Formulation and to Assess The Effect of High Fat Diet in Healthy Male Subjects
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 17 Jun 2014
Price :
$35
*
At a glance
- Drugs Pregabalin (Primary)
- Indications Epilepsy; Fibromyalgia; Generalised anxiety disorder; Neuropathic pain; Postherpetic neuralgia
- Focus Pharmacokinetics
- Acronyms GLA5PR-101
- Sponsors GL PharmTech
- 01 Nov 2012 Status changed from not yet recruiting to completed as reported by ClinicalTrials.gov.
- 17 Jul 2012 New trial record